Leber hereditary optic neuropathy - Therapeutic challenges and early promise

0Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Leber hereditary optic neuropathy (LHON) is the most common primary mitochondrial DNA (mtDNA) disorder in the general population. It is an important cause of severe, usually irreversible, visual loss among young adults with a peak age of onset in the second and third decades of life. Management is currently mostly supportive but recent developments in LHON research are pointing the way towards more effective treatments for this blinding mitochondrial disorder. © 2011, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC.

Cite

CITATION STYLE

APA

Yu-Wai-Man, P., & Chinnery, P. F. (2011). Leber hereditary optic neuropathy - Therapeutic challenges and early promise. Taiwan Journal of Ophthalmology. Elsevier B.V. https://doi.org/10.1016/j.tjo.2011.09.001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free